California Public Employees Retirement System Purchases 3,998 Shares of Amedisys, Inc. (NASDAQ:AMED)

California Public Employees Retirement System boosted its position in shares of Amedisys, Inc. (NASDAQ:AMEDFree Report) by 6.9% during the 3rd quarter, HoldingsChannel reports. The fund owned 61,609 shares of the health services provider’s stock after buying an additional 3,998 shares during the quarter. California Public Employees Retirement System’s holdings in Amedisys were worth $5,754,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Alpine Associates Management Inc. acquired a new stake in Amedisys during the second quarter valued at approximately $64,483,000. Mackenzie Financial Corp boosted its holdings in Amedisys by 67.7% during the first quarter. Mackenzie Financial Corp now owns 956,780 shares of the health services provider’s stock valued at $164,844,000 after purchasing an additional 386,411 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Amedisys by 222.6% in the 4th quarter. Millennium Management LLC now owns 478,081 shares of the health services provider’s stock worth $39,939,000 after acquiring an additional 329,891 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Amedisys by 708.8% in the 2nd quarter. Alliancebernstein L.P. now owns 357,349 shares of the health services provider’s stock worth $32,676,000 after acquiring an additional 313,169 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of Amedisys in the 4th quarter worth approximately $26,014,000. 95.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Amedisys in a report on Saturday. They issued a “buy” rating on the stock. Eight equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Amedisys has an average rating of “Hold” and an average target price of $103.22.

Get Our Latest Analysis on Amedisys

Amedisys Stock Down 0.2 %

NASDAQ:AMED opened at $95.02 on Wednesday. The stock’s fifty day moving average price is $94.48 and its two-hundred day moving average price is $93.31. Amedisys, Inc. has a 52-week low of $69.36 and a 52-week high of $106.01. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.00 and a current ratio of 1.00. The company has a market cap of $3.10 billion, a price-to-earnings ratio of 1,357.62, a P/E/G ratio of 2.15 and a beta of 0.89.

Amedisys Profile

(Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Recommended Stories

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys, Inc. (NASDAQ:AMEDFree Report).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.